WuXi PharmaTech Inc., a pharmaceutical, biotechnology, and medical deviceresearch and development outsourcing company with operations in China and theUnited States, has announced that Felix Hsu has been appointed Senior VicePresident of WuXi AppTec U.S. Prior to joining WuXi, Mr. Hsu worked at Medtronic for 14 years inpositions of increasing responsibility. He has broad experience as a productmanager and business leader, serving as Director of Heart Valve WorldwideMarketing; Vice President of Business Excellence; Vice President of CardiacSurgery for Asia Pacific, based in Hong Kong; and Vice President of SupplyChain Integration based in Minneapolis. Prior to working at Medtronic, heserved in product management, sales management, and strategic planning rolesat Abbott Laboratories and as a business manager at Sabratek. In these roles,he was successful in driving revenue growth through effective productmanagement and in implementing strategies to improve operational excellenceand reduce costs. In his new role, Mr. Hsu will be responsible for WuXi’s U.S. business. Asignificant portion of U.S. revenues are derived from serving the medicaldevice industry, where Mr. Hsu has extensive experience. He will report toEdward Hu, Chief Operating Officer, acting Chief Financial Officer, andcurrent head of U.S. operations. “I am very pleased to welcome Felix on board as we continue to strengthenour U.S. management team,” commented Dr. Ge Li, Chairman and Chief ExecutiveOfficer of WuXi PharmaTech. “Our U.S. operations offer a range of testingservices critical to the successful development and regulatory approval of newbiologics and medical devices. We expect our U.S. business will grow underFelix’s leadership.”
